Regulation of Colonic Epithelial Repair in Mice by Toll-Like Receptors and Hyaluronic Acid
Background & Aims
The protective component of the host response to dextran sodium sulfate (DSS)-induced colitis in the mouse is mediated through the activation of Toll-like receptor (TLR) 4, the induction of cyclooxygenase (COX)-2, and prostaglandin E2 production. TLR4 ligands include bacterial lipopolysaccharide and hyaluronic acid, a component of the extracellular matrix. Our hypothesis is that hyaluronic acid, through TLRs, plays a protective role in the host response to DSS-induced colitis.
Methods
DSS (2.5%) was administered for 7 days in wild-type and MyD88−/− mice. The mice also received intraperitoneal hyaluronic acid. The expression of hyaluronic acid, COX-2, and macrophage inflammatory protein (MIP)-2 was evaluated by immunohistochemistry.
Results
DSS induced a marked increase in hyaluronic acid in the lamina propria of wild-type but not MyD88−/− mice. Treatment with DSS also induced the MyD88-dependent expression of hyaluronic acid synthases 2 and 3, enzymes involved in hyaluronic acid synthesis, in lamina propria macrophages. Exogenous hyaluronic acid induced the expression of tumor necrosis factor α, MIP-2, and COX-2 in the colon in a MyD88-dependent manner. In wild-type but not MyD88−/−, TLR4−/−, COX-2−/− mice, hyaluronic acid was protective against DSS-induced colitis. In wild-type mice, hyaluronic acid was therapeutic in established DSS-induced colitis.
Conclusions
Endogenous hyaluronic acid expression is markedly increased in DSS-induced colitis and preserves the epithelium through TLR activation and COX-2 expression. Furthermore, exogenous hyaluronic acid, through the activation of TLRs and the production of prostaglandin E2 through COX-2, has protective effects in DSS-induced colitis.
Abbreviations used in this paper: COX, cyclooxygenase, DSS, dextran sodium sulfate, HA, hyaluronic acid, HAS, hyaluronic acid synthase, LPS, lipopolysaccharide, MIP, macrophage inflammatory protein, TLR, Toll-like receptor, TNF, tumor necrosis factor, WT, wild-type
To access this article, please choose from the options below
Conflicts of interest The authors disclose no conflicts.
Funding Supported by National Institutes of Health grants R01DK33165 and R01DK55753.
PII: S0016-5085(09)01545-5
doi:10.1053/j.gastro.2009.08.055
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
- A Feed-Forward Loop Involving Hyaluronic Acid and Toll-Like Receptor-4 as a Treatment for Colitis? , 30 October 2009

